Az eritropoetin új lehetoség a kissejtes tüdodaganat okozta anémia kezelésében - Esetbemutatás

Translated title of the contribution: Erythropoietin is a novel therapeutic option in the treatment of anemia caused by small cell lung cancer

L. Tamási, Anikó Bohács, András Wollák, P. Magyar

Research output: Contribution to journalArticle

Abstract

Anemia is very common among patients with malignant tumors, due to the disease and chemotherapy. Anemia decreases the patient's quality of life. Erythropoietin therapy is accessible in Hungary for the treatment of chemotherapy-induced anemia in patients suffering from small cell lung cancer. In our case report we present the case of a 62-year-old female small cell lung cancer patient with severe anemia, treated by erythropoietin-beta. The erythropoietin treatment provided the possibility of effective chemo- and radiotherapy. The patient's quality of life greatly improved due to the lack of the symptoms of anemia. The adequate use of erythropoietin is of great help to the physician in the management of small cell lung cancer patients, by improving the quality of life.

Original languageHungarian
Pages (from-to)243-246
Number of pages4
JournalMagyar Onkologia
Volume50
Issue number3
Publication statusPublished - 2006

Fingerprint

Small Cell Lung Carcinoma
Erythropoietin
Anemia
Quality of Life
Drug Therapy
Therapeutics
Hungary
Radiotherapy
Physicians
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Az eritropoetin új lehetoség a kissejtes tüdodaganat okozta anémia kezelésében - Esetbemutatás. / Tamási, L.; Bohács, Anikó; Wollák, András; Magyar, P.

In: Magyar Onkologia, Vol. 50, No. 3, 2006, p. 243-246.

Research output: Contribution to journalArticle

@article{6a14991f8e5548daa4f02cd795c4063b,
title = "Az eritropoetin {\'u}j lehetos{\'e}g a kissejtes t{\"u}dodaganat okozta an{\'e}mia kezel{\'e}s{\'e}ben - Esetbemutat{\'a}s",
abstract = "Anemia is very common among patients with malignant tumors, due to the disease and chemotherapy. Anemia decreases the patient's quality of life. Erythropoietin therapy is accessible in Hungary for the treatment of chemotherapy-induced anemia in patients suffering from small cell lung cancer. In our case report we present the case of a 62-year-old female small cell lung cancer patient with severe anemia, treated by erythropoietin-beta. The erythropoietin treatment provided the possibility of effective chemo- and radiotherapy. The patient's quality of life greatly improved due to the lack of the symptoms of anemia. The adequate use of erythropoietin is of great help to the physician in the management of small cell lung cancer patients, by improving the quality of life.",
author = "L. Tam{\'a}si and Anik{\'o} Boh{\'a}cs and Andr{\'a}s Woll{\'a}k and P. Magyar",
year = "2006",
language = "Hungarian",
volume = "50",
pages = "243--246",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "3",

}

TY - JOUR

T1 - Az eritropoetin új lehetoség a kissejtes tüdodaganat okozta anémia kezelésében - Esetbemutatás

AU - Tamási, L.

AU - Bohács, Anikó

AU - Wollák, András

AU - Magyar, P.

PY - 2006

Y1 - 2006

N2 - Anemia is very common among patients with malignant tumors, due to the disease and chemotherapy. Anemia decreases the patient's quality of life. Erythropoietin therapy is accessible in Hungary for the treatment of chemotherapy-induced anemia in patients suffering from small cell lung cancer. In our case report we present the case of a 62-year-old female small cell lung cancer patient with severe anemia, treated by erythropoietin-beta. The erythropoietin treatment provided the possibility of effective chemo- and radiotherapy. The patient's quality of life greatly improved due to the lack of the symptoms of anemia. The adequate use of erythropoietin is of great help to the physician in the management of small cell lung cancer patients, by improving the quality of life.

AB - Anemia is very common among patients with malignant tumors, due to the disease and chemotherapy. Anemia decreases the patient's quality of life. Erythropoietin therapy is accessible in Hungary for the treatment of chemotherapy-induced anemia in patients suffering from small cell lung cancer. In our case report we present the case of a 62-year-old female small cell lung cancer patient with severe anemia, treated by erythropoietin-beta. The erythropoietin treatment provided the possibility of effective chemo- and radiotherapy. The patient's quality of life greatly improved due to the lack of the symptoms of anemia. The adequate use of erythropoietin is of great help to the physician in the management of small cell lung cancer patients, by improving the quality of life.

UR - http://www.scopus.com/inward/record.url?scp=39049190633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049190633&partnerID=8YFLogxK

M3 - Article

C2 - 17099785

AN - SCOPUS:39049190633

VL - 50

SP - 243

EP - 246

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 3

ER -